Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-777991 in Adults With Non-segmental Vitiligo
NCT07667569Phase 2Recruiting
- Sponsor
- Idorsia
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 2
01
Overview
A Phase 2 trial of ACT-777991 in Vitiligo, sponsored by Idorsia. Started Oct 2026; status: recruiting.
02
Drugs
ACT-777991
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07667569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07667569.